Skip to main content
. 2019 Aug;14(8):1455–1461. doi: 10.4103/1673-5374.253531

Figure 6.

Figure 6

SUMO2/3 protein expression in sciatic nerve.

(A) Detection of SUMO2/3 levels in covalent and free states by western blot assay. (B) Quantification of expression of SUMO2/3 in each group: GAPDH was used as an internal control. **P < 0.01, vs. sham group (mean ± SD, n = 4, one-way analysis of variance followed by Tukey’s honestly significant difference post hoc test). SUMO: Small ubiquitin-like modifier; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; d: day(s).